About Johnson Pharmacare Limited
Data last updated:
Johnson Pharmacare Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 June 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L51100GJ1994PLC022388. The company has 1 GST registration on record, which is no longer active. It is a listed company as per MCA records. Its shares are listed on BSE: 532154.
The company has an authorised share capital of ₹55 Cr and a paid-up capital of ₹55 Cr. It was formerly known as Robinson Worldwide Trade Limited and Sun and Shine Worldwide Limited. It is led by directors including Parul Agrawal and Babita.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Ahmedabad, Gujarat.
The company is associated with 2 brands: Johnsonpharmacareltd and Sun and Shine Worldwide Trade. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it; 6 cases are pending. The company has 50 deals on record (50 market trades); the latest was in July 2024.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunandshineworldwidetradelimited.in.
Company details
Name history
Johnson Pharmacare has undergone 2 name changes throughout its history. The company was previously known as Robinson Worldwide Trade Limited, and Sun And Shine Worldwide Limited. The current legal name is Johnson Pharmacare Limited.
| Company Name | Status |
|---|---|
| Johnson Pharmacare Limited | Current |
| Robinson Worldwide Trade Limited | Previous |
| Sun And Shine Worldwide Limited | Previous |
CIN history
Johnson Pharmacare has one previous CIN (Corporate Identification Number): U51100GJ1994PLC022388. The current CIN is L51100GJ1994PLC022388, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L51100GJ1994PLC022388 | Current |
| U51100GJ1994PLC022388 | Previous |
Contact details
Johnson Pharmacare Limited's registered office is in Ahmedabad, Gujarat. Its website is sunandshineworldwidetradelimited.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No. 4 – D Fourth Floor Vardan Tower, Lakhudi Circle Near Sardar Patel Stadium Navrangpura, Ahmedabad, Gujarat, India – 380009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Johnson Pharmacare Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Johnson Pharmacare operates two associated brands: Johnsonpharmacareltd and Sun and Shine Worldwide Trade. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceuticals and healthcare products are wholesaled and retailed. | johnsonpharmacareltd.live | |
| International trade services, including export-import and logistics operations in India. | sunandshineworldwidetradelimited.in |
Financials of Johnson Pharmacare Limited
FY 2025-26 filings availableJohnson Pharmacare Limited reported revenue of ₹- for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 0.00 | 0.00 | 0.00 | 2.53 | 3.26 | 0.76 | 0.00 |
| Revenue growth | - | - | -100.0% | -22.4% | +329.0% | - | - |
| EBITDA | (57.05) | (0.58) | (0.20) | (1.32) | 0.13 | 0.01 | (0.09) |
| EBITDA margin | - | - | - | -52.2% | +4.0% | +1.3% | - |
| Profit before tax | (55.73) | (0.58) | (0.20) | (1.32) | 0.13 | 0.01 | (0.09) |
| Net profit | (41.46) | (0.25) | (0.20) | 0.27 | 0.09 | 0.01 | (0.09) |
| Net profit margin | - | - | - | +10.7% | +2.8% | +1.3% | - |
| EPS (₹) | (1.01) | (0.01) | 0.00 | (0.02) | 0.00 | 0.00 | (0.02) |
| Balance sheet | |||||||
| Total assets | - | 56.77 | 58.70 | 58.85 | 58.85 | 58.83 | 58.77 |
| Net worth | - | 56.17 | 56.75 | 56.95 | 58.24 | 58.14 | 58.14 |
| Total debt | - | 0.61 | 1.96 | 1.91 | 0.61 | 0.69 | 0.63 |
| Cash & bank | - | 0.01 | 0.00 | 0.00 | 0.04 | 0.23 | 0.28 |
| Net working capital | - | 0.21 | (1.13) | (0.98) | (0.04) | 4.95 | 4.89 |
| Cash flow | |||||||
| Cash from operations | - | (1.91) | (0.05) | (0.40) | 4.90 | (0.11) | 0.17 |
| Cash from investing | - | 3.27 | 0.00 | (0.94) | (5.01) | 0.00 | 0.88 |
| Cash from financing | - | (1.35) | 0.05 | 1.30 | (0.08) | 0.06 | (1.07) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other income | 0.00 | 1.58 | 0.00 | 0.00 | 0.00 | (0.33) | 0.00 | 0.00 |
| Total expenses | 0.04 | 56.97 | 0.02 | 0.00 | 0.05 | 0.18 | 0.03 | 0.00 |
| EBITDA | (0.04) | (56.97) | (0.02) | 0.00 | (0.05) | (0.18) | (0.03) | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 1.06 | 0.22 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (1.10) | (55.61) | (0.06) | 0.00 | (0.05) | (0.51) | (0.03) | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other income | 0.00 | 1.58 | 0.00 | 0.00 | 0.00 | (0.33) | 0.00 | 0.00 |
| Total expenses | 0.04 | 56.97 | 0.02 | 0.00 | 0.05 | 0.18 | 0.03 | 0.00 |
| EBITDA | (0.04) | (56.97) | (0.02) | 0.00 | (0.05) | (0.18) | (0.03) | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 1.06 | 0.22 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (1.10) | (55.61) | (0.06) | 0.00 | (0.05) | (0.51) | (0.03) | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 2.53 | 3.26 | 0.76 | 0.00 |
| Revenue growth | - | - | -100.0% | -22.4% | +329.0% | - | - |
| Other income | 1.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total expenses | 57.05 | 0.58 | 0.20 | 3.85 | 3.13 | 0.75 | 0.09 |
| Employee cost | 0.00 | 0.01 | 0.00 | 0.07 | 0.10 | 0.02 | 0.02 |
| EBITDA | (57.05) | (0.58) | (0.20) | (1.32) | 0.13 | 0.01 | (0.09) |
| EBITDA margin | - | - | - | -52.2% | +4.0% | +1.3% | - |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (55.73) | (0.58) | (0.20) | (1.32) | 0.13 | 0.01 | (0.09) |
| Tax | 0.00 | 0.00 | 0.00 | (0.04) | 0.04 | 0.00 | 0.00 |
| Net profit | (41.46) | (0.25) | (0.20) | 0.27 | 0.09 | 0.01 | (0.09) |
| Net profit margin | - | - | - | +10.7% | +2.8% | +1.3% | - |
| EPS (₹) | (1.01) | (0.01) | 0.00 | (0.02) | 0.00 | 0.00 | (0.02) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 55.00 | 55.00 | 55.00 | 55.00 | 50.00 | 50.00 |
| Reserves & surplus | - | 1.17 | 1.75 | 1.95 | 3.24 | 8.14 | 8.14 |
| Shareholders' funds (net worth) | - | 56.17 | 56.75 | 56.95 | 58.24 | 58.14 | 58.14 |
| Secured loans | - | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 |
| Unsecured loans | - | 0.00 | 1.35 | 1.30 | 0.00 | 0.08 | 0.02 |
| Total debt | - | 0.61 | 1.96 | 1.91 | 0.61 | 0.69 | 0.63 |
| Total liabilities | - | 56.77 | 58.70 | 58.85 | 58.85 | 58.83 | 58.77 |
| Assets | |||||||
| Gross block | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net block | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital work in progress | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | - | 42.29 | 45.56 | 45.56 | 54.18 | 52.26 | 52.26 |
| Inventories | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | - | 0.00 | 0.00 | 0.00 | 1.05 | 1.68 | 0.92 |
| Cash & bank balances | - | 0.01 | 0.00 | 0.00 | 0.04 | 0.23 | 0.28 |
| Loans & advances | - | 1.35 | 0.00 | 0.00 | 0.00 | 3.69 | 3.69 |
| Total current assets | - | 1.36 | 0.00 | 0.00 | 1.09 | 5.60 | 4.89 |
| Total current liabilities | - | 1.15 | 1.13 | 0.98 | 1.13 | 0.65 | 0.00 |
| Net working capital | - | 0.21 | (1.13) | (0.98) | (0.04) | 4.95 | 4.89 |
| Total assets | - | 56.77 | 58.70 | 58.85 | 58.85 | 58.83 | 58.77 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 0.00 | 0.00 | 0.04 | 0.23 | 0.28 | 0.30 |
| Net cash from operating activities | - | (1.91) | (0.05) | (0.40) | 4.90 | (0.11) | 0.17 |
| Net cash from investing activities | - | 3.27 | 0.00 | (0.94) | (5.01) | 0.00 | 0.88 |
| Net cash from financing activities | - | (1.35) | 0.05 | 1.30 | (0.08) | 0.06 | (1.07) |
| Net change in cash | - | 0.01 | 0.00 | (0.04) | (0.19) | (0.05) | (0.03) |
| Closing cash | - | 0.01 | 0.00 | 0.00 | 0.04 | 0.23 | 0.28 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | - | - | -100.0% | -22.4% | +329.0% | - | - |
| EBITDA growth | -9736.2% | -190.0% | +84.9% | -1115.4% | +1200.0% | +111.1% | - |
| PBT growth | -9508.6% | -190.0% | +84.9% | - | +1200.0% | +9998.0% | -800.0% |
| Net income growth | - | -25.0% | -174.1% | +200.0% | +800.0% | +111.1% | - |
| Revenue CAGR (3Y) | -100.0% | -100.0% | -100.0% | - | +52.5% | - | - |
| EBITDA CAGR (3Y) | +250.9% | - | - | +144.8% | - | - | -9.1% |
| Profitability & leverage | |||||||
| Net income margin | - | - | - | -50.6% | +2.8% | +1.3% | - |
| Return on capital employed | - | 0.0% | 0.0% | 0.0% | +0.2% | 0.0% | 0.0% |
| Return on net worth | - | 0.0% | 0.0% | 0.0% | +0.2% | 0.0% | 0.0% |
| Debt / equity | - | 0.02 | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 |
| Long-term debt / equity | - | 0.02 | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 |
| Interest cover | -0.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory turnover | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | - | 0.00 | 0.00 | 4.82 | 2.39 | 0.58 | 0.00 |
| EPS (₹) | (1.01) | (0.01) | 0.00 | (0.02) | 0.00 | 0.00 | (0.02) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 1.02 | 1.03 | 1.04 | 1.06 | 11.63 | 11.63 |
To see the full year-wise statements and ratios of Johnson Pharmacare Limited, buy the company report.
Board of directors of Johnson Pharmacare Limited
Johnson Pharmacare has 4 current directors and 33 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parul Agrawal | Additional Director | 06 Oct 2025 | 1 Years 0 Months | Current |
| Babita Also directs: BKB & Associates LLP, Auxilia Foundation | Additional Director | 12 Sep 2025 | 1 Years 1 Months | Current |
| Nand Kishor Ray | Additional Director | 17 Apr 2026 | 0 Years 6 Months | Current |
| Dheeraj Kumar | Additional Director | 17 Apr 2026 | 0 Years 6 Months | Current |
Auditor
Johnson Pharmacare Limited is audited by RISHI SEKHRI A N D ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RISHI SEKHRI A N D ASSOCIATES | FY 2023 | 128216W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 0.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 100.00%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 100.00% | 100.00% | 100.00% | 100.00% |
Deals & funding
Johnson Pharmacare Limited has 50 deals on record (50 market trades); the latest was in July 2024.
Deals on record (5 of 50)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2024 | Market trade | ₹1.47 Cr | Buyer: Topgain Finance Private Limited Seller: Multiplier Share and Stock Advisors Private Limited , Topgain Finance Private Limited |
| Jul 2024 | Market trade | ₹31.9 Lakh | Buyer: Multiplier Share and Stock Advisors Private Limited Seller: Multiplier Share and Stock Advisors Private Limited |
| Jun 2024 | Market trade | ₹47.9 Lakh | Buyer: Topgain Finance Private Limited Seller: Multiplier Share and Stock Advisors Private Limited |
| Jan 2024 | Market trade | ₹29.4 Lakh | Seller: Topgain Finance Private Limited |
| Jan 2024 | Market trade | ₹30 Lakh | Buyer: Topgain Finance Private Limited Seller: Topgain Finance Private Limited |
To see the full deal history of Johnson Pharmacare Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Johnson Pharmacare Limited has 8 court cases on record: 2 filed by Johnson Pharmacare, 6 filed against it. 6 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 6 | 4 |
| High courts | 1 | 0 | 1 |
| Supreme Court | 1 | 0 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by an individual | Pending |
| High Court of Gujarat | Special civil application | Filed by the company against an individual | Pending |
| District court, Ahmedabad, Gujarat | Court case (SPCS COMP) | Filed against the company by an individual | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by The Registrar of Companies | Pending |
| Supreme Court | Court case (4201-SEBI Act and Securities Laws including Forward Contract Regulation Act, 1952 and Securities Contracts (Regulation) Act, 1956 : SEBI Act and Securities Laws including Forward Contract Regulation Act, 1952 and Securities Contracts (Regulation) Act, 1956) | Filed by the company against Securities and Exchange Board of India Through Director, Sebi Bhawan, Plot C4-A, G-Block, Bandra Kurla Complex, Bandra (E), Mumbai , District: Mumbai ,Mumbai , Maharashtra | Pending |
To see the full case history of Johnson Pharmacare Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Johnson Pharmacare Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Johnson Pharmacare has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Johnson Pharmacare Limited, buy the company report.
Recent activity
Johnson Pharmacare Limited has 64 board changes on record since 2001: 35 appointments and 29 cessations. The latest: Dheeraj Kumar was appointed as Additional Director on 17 Apr 2026.
55 earlier events are in the company report.
News
Frequently asked questions
Johnson Pharmacare is an active public limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 June 1994 (32+ years old) and is registered under CIN L51100GJ1994PLC022388. Listed on BSE: 532154.
Johnson Pharmacare has 4 current directors:
- Parul Agrawal - Additional Director
- Babita - Additional Director
- Nand Kishor Ray - Additional Director
- Dheeraj Kumar - Additional Director
The latest financial statements of Johnson Pharmacare on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
No. Johnson Pharmacare has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Johnson Pharmacare is L51100GJ1994PLC022388. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Johnson Pharmacare is a listed company as per MCA records. Its shares are listed on BSE (code: 532154).
Johnson Pharmacare has 8 court cases on record: 2 filed by the company and 6 filed against it. 6 are pending. Most are in the district courts.
Johnson Pharmacare was incorporated on 30 June 1994, making it 32+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Johnson Pharmacare has 50 deals on record (50 market trades); the latest was in July 2024.
Dheeraj Kumar was appointed as Additional Director on 17 Apr 2026. Nand Kishor Ray was appointed as Additional Director on 17 Apr 2026. Pareshbhai Ganpatbhai Sengal ceased to be Director on 27 Oct 2025. Johnson Pharmacare has 64 board changes on record in total.